☰

Lionel Larue, Dr Claude Paoletti - Publications

Affiliations: 
CNRS UMR 3347 / Inserm U1021 Institut Curie, Bures-sur-Yvette, Île-de-France, France 
Area:
Normal and pathological development of melanocytes
Website:
http://umr3347.curie.fr/en/profile/lionel-larue-00107
Tree Info Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Aktary Z, Raymond JH, Pouteaux M, Delmas V, Petit V, Larue L. Derivation and Use of Cell Lines from Mouse Models of Melanoma. The Journal of Investigative Dermatology. 143: 538-544.e2. PMID 36958885 DOI: 10.1016/j.jid.2023.01.005  0.319
2021 Montaudié H, Sormani L, Dadone-Montaudié B, Heim M, Cardot-Leccia N, Tulic MK, Beranger G, Gay AS, Debayle D, Cheli Y, Raymond JH, Sohier P, Petit V, Rocchi S, Gesbert F, ... Larue L, et al. CLEC12B decreases melanoma proliferation by repressing STAT3. The Journal of Investigative Dermatology. PMID 34310951 DOI: 10.1016/j.jid.2021.05.035  0.313
2021 Dilshat R, Fock V, Kenny C, Gerritsen I, Lasseur RMJ, Travnickova J, Eichhoff OM, Cerny P, Möller K, Sigurbjörnsdóttir S, Kirty K, Einarsdottir BÓ, Cheng PF, Levesque M, Cornell RA, ... ... Larue L, et al. MITF reprograms the extracellular matrix and focal adhesion in melanoma. Elife. 10. PMID 33438577 DOI: 10.7554/eLife.63093  0.321
2020 Swoboda A, Soukup R, Eckel O, Kinslechner K, Wingelhofer B, Schörghofer D, Sternberg C, Pham HTT, Vallianou M, Horvath J, Stoiber D, Kenner L, Larue L, Poli V, Beermann F, et al. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway. Oncogene. PMID 33323974 DOI: 10.1038/s41388-020-01584-6  0.334
2019 Boussouar A, Tortereau A, Manceau A, Paradisi A, Gadot N, Vial J, Neves D, Larue L, Battistella M, Leboeuf C, Lebbé C, Janin A, Mehlen P. Netrin-1 and its receptor DCC are causally implicated in melanoma progression. Cancer Research. PMID 31806640 DOI: 10.1158/0008-5472.Can-18-1590  0.417
2019 Aktary Z, Corvelo A, Estrin C, Larue L. Sequencing two Tyr::CreER transgenic mouse lines. Pigment Cell & Melanoma Research. PMID 31679174 DOI: 10.1111/Pcmr.12842  0.36
2019 Petit V, Raymond J, Alberti C, Pouteaux M, Gallagher SJ, Nguyen MQ, Aplin AE, Delmas V, Larue L. C57BL/6 congenic mouse NRAS melanoma cell lines are highly sensitive to the combination of MEK and AKT inhibitors in vitro and in vivo. Pigment Cell & Melanoma Research. PMID 31251472 DOI: 10.1111/Pcmr.12807  0.394
2019 Laurette P, Coassolo S, Davidson G, Michel I, Gambi G, Yao W, Sohier P, Li M, Mengus G, Larue L, Davidson I. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma. Cell Death and Differentiation. PMID 31065107 DOI: 10.1038/S41418-019-0333-6  0.428
2019 Herbert K, Binet R, Lambert JP, Louphrasitthiphol P, Kalkavan H, Sesma-Sanz L, Robles-Espinoza CD, Sarkar S, Suer E, Andrews S, Chauhan J, Roberts ND, Middleton MR, Gingras AC, Masson JY, ... Larue L, et al. BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma. Genes & Development. PMID 30804224 DOI: 10.1101/Gad.314633.118  0.305
2019 Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz RA, Dorjsuren DG, Sun H, Simeonov A, Giordano A, ... ... Larue L, et al. Thymine DNA glycosylase as a novel target for melanoma. Oncogene. PMID 30674989 DOI: 10.1038/S41388-018-0640-2  0.355
2018 Delmas V, Larue L. Molecular and cellular basis of depigmentation in vitiligo patients. Experimental Dermatology. PMID 30536790 DOI: 10.1111/Exd.13858  0.354
2018 Gesbert F, Larue L. [Cutaneous melanoma: from rationalized models to patients care]. Medecine Sciences : M/S. 34: 407-416. PMID 29900843 DOI: 10.1051/Medsci/20183405013  0.379
2018 Laurent P, Petit V, Aktary Z, Gallagher S, Tweedy L, Machesky L, Larue L. Simulation of melanoblast displacements reveals new features of developmental migration. Development (Cambridge, England). PMID 29769218 DOI: 10.1242/Dev.160200  0.3
2018 Sukseree S, László L, Gruber F, Bergmann S, Narzt MS, Nagelreiter IM, Höftberger R, Molnár K, Rauter G, Birngruber T, Larue L, Kovacs GG, Tschachler E, Eckhart L. Filamentous Aggregation of Sequestosome-1/p62 in Brain Neurons and Neuroepithelial Cells upon Tyr-Cre-Mediated Deletion of the Autophagy Gene Atg7. Molecular Neurobiology. PMID 29550918 DOI: 10.1007/S12035-018-0996-X  0.348
2017 Sohier P, Legrand L, Aktary Z, Grill C, Delmas V, Bernex F, Reyes-Gomez E, Larue L, Vergier B. A histopathological classification system of Tyr::NRASQ61K murine melanocytic lesions: A reproducible simplified classification. Pigment Cell & Melanoma Research. PMID 29224244 DOI: 10.1111/Pcmr.12677  0.302
2017 Kinsler VA, Larue L. The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation. Pigment Cell & Melanoma Research. PMID 28940934 DOI: 10.1111/Pcmr.12645  0.319
2017 Woodham EF, Paul NR, Tyrrell B, Spence HJ, Swaminathan K, Scribner MR, Giampazolias E, Hedley A, Clark W, Kage F, Marston DJ, Hahn KM, Tait SW, Larue L, Brakebusch CH, et al. Coordination by Cdc42 of Actin, Contractility, and Adhesion for Melanoblast Movement in Mouse Skin. Current Biology : Cb. PMID 28238662 DOI: 10.1016/J.Cub.2017.01.033  0.355
2017 Petit V, Delmas V, Beermann F, Larue L. 563 Establishment of in vivo and in vitro mouse models relevant for human cutaneous melanoma mutated for NRAS Journal of Investigative Dermatology. 137. DOI: 10.1016/J.Jid.2017.07.760  0.315
2016 Sukseree S, Chen YT, Laggner M, Gruber F, Petit V, Nagelreiter IM, Mlitz V, Rossiter H, Pollreisz A, Schmidt-Erfurth U, Larue L, Tschachler E, Eckhart L. Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice. Plos One. 11: e0161640. PMID 27537685 DOI: 10.1371/Journal.Pone.0161640  0.362
2015 Loriot C, Domingues M, Berger A, Menara M, Ruel M, Morin A, Castro-Vega LJ, Letouzé É, Martinelli C, Bemelmans AP, Larue L, Gimenez-Roqueplo AP, Favier J. Deciphering the molecular basis of invasiveness in Sdhb-deficient cells. Oncotarget. PMID 26460615 DOI: 10.18632/Oncotarget.5106  0.33
2015 Koludrovic D, Laurette P, Strub T, Keime C, Le Coz M, Coassolo S, Mengus G, Larue L, Davidson I. Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells. Plos Genetics. 11: e1005555. PMID 26440048 DOI: 10.1371/journal.pgen.1005555  0.333
2014 Denecker G, Vandamme N, Akay O, Koludrovic D, Taminau J, Lemeire K, Gheldof A, De Craene B, Van Gele M, Brochez L, Udupi GM, Rafferty M, Balint B, Gallagher WM, Ghanem G, ... ... Larue L, et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death and Differentiation. 21: 1250-61. PMID 24769727 DOI: 10.1038/Cdd.2014.44  0.363
2014 Domingues MJ, Rambow F, Job B, Papon L, Liu W, Larue L, Bonaventure J. β-catenin inhibitor ICAT modulates the invasive motility of melanoma cells. Cancer Research. 74: 1983-95. PMID 24514042 DOI: 10.1158/0008-5472.CAN-13-0920  0.301
2013 Domingues MJ, Larue L, Bonaventure J. [Migration of melanocytic lineage-derived cells]. MéDecine Sciences : M/S. 29: 287-92. PMID 23544383 DOI: 10.1051/medsci/2013293015  0.328
2013 Bonaventure J, Domingues MJ, Larue L. Cellular and molecular mechanisms controlling the migration of melanocytes and melanoma cells. Pigment Cell & Melanoma Research. 26: 316-25. PMID 23433358 DOI: 10.1111/pcmr.12080  0.332
2012 Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S, Zwolinska A, Haupt S, de Lange J, Yip D, Goydos J, Haigh JJ, Haupt Y, Larue L, Jochemsen A, et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nature Medicine. 18: 1239-47. PMID 22820643 DOI: 10.1038/Nm.2863  0.331
2012 Colombo S, Champeval D, Rambow F, Larue L. Transcriptomic analysis of mouse embryonic skin cells reveals previously unreported genes expressed in melanoblasts. The Journal of Investigative Dermatology. 132: 170-8. PMID 21850021 DOI: 10.1038/jid.2011.252  0.306
2011 Luciani F, Champeval D, Herbette A, Denat L, Aylaj B, Martinozzi S, Ballotti R, Kemler R, Goding CR, De Vuyst F, Larue L, Delmas V. Biological and mathematical modeling of melanocyte development. Development (Cambridge, England). 138: 3943-54. PMID 21862558 DOI: 10.1242/dev.067447  0.301
2011 Mayola E, Gallerne C, Esposti DD, Martel C, Pervaiz S, Larue L, Debuire B, Lemoine A, Brenner C, Lemaire C. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis : An International Journal On Programmed Cell Death. 16: 1014-27. PMID 21710254 DOI: 10.1007/S10495-011-0625-X  0.326
2010 Dhomen N, Da Rocha Dias S, Hayward R, Ogilvie L, Hedley D, Delmas V, McCarthy A, Henderson D, Springer CJ, Pritchard C, Larue L, Marais R. Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality. Pigment Cell & Melanoma Research. 23: 112-20. PMID 20002887 DOI: 10.1111/j.1755-148X.2009.00662.x  0.328
2009 Puig I, Champeval D, De Santa Barbara P, Jaubert F, Lyonnet S, Larue L. Deletion of Pten in the mouse enteric nervous system induces ganglioneuromatosis and mimics intestinal pseudoobstruction. The Journal of Clinical Investigation. 119: 3586-96. PMID 19884655 DOI: 10.1172/Jci39929  0.31
2009 Dhomen N, Reis-Filho JS, da Rocha Dias S, Hayward R, Savage K, Delmas V, Larue L, Pritchard C, Marais R. Oncogenic Braf induces melanocyte senescence and melanoma in mice. Cancer Cell. 15: 294-303. PMID 19345328 DOI: 10.1016/j.ccr.2009.02.022  0.324
2007 Javelaud D, Mohammad KS, McKenna CR, Fournier P, Luciani F, Niewolna M, André J, Delmas V, Larue L, Guise TA, Mauviel A. Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Research. 67: 2317-24. PMID 17332363 DOI: 10.1158/0008-5472.Can-06-3950  0.311
2006 Moriyama M, Osawa M, Mak SS, Ohtsuka T, Yamamoto N, Han H, Delmas V, Kageyama R, Beermann F, Larue L, Nishikawa S. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells. The Journal of Cell Biology. 173: 333-9. PMID 16651378 DOI: 10.1083/Jcb.200509084  0.359
2006 Yajima I, Belloir E, Bourgeois Y, Kumasaka M, Delmas V, Larue L. Spatiotemporal gene control by the Cre-ERT2 system in melanocytes. Genesis (New York, N.Y. : 2000). 44: 34-43. PMID 16419042 DOI: 10.1002/gene.20182  0.302
2004 Moore R, Larue L. Cell surface molecules and truncal neural crest ontogeny: a perspective. Birth Defects Research. Part C, Embryo Today : Reviews. 72: 140-50. PMID 15269888 DOI: 10.1002/Bdrc.20014  0.321
2004 Pla P, Solov'Eva O, Moore R, Alberti C, Kunisada T, Larue L. Dct::lacZ ES Cells: A Novel Cellular Model to Study Melanocyte Determination and Differentiation Pigment Cell Research. 17: 142-149. PMID 15016303 DOI: 10.1046/j.1600-0749.2003.00121.x  0.306
2003 Delmas V, Martinozzi S, Bourgeois Y, Holzenberger M, Larue L. Cre-mediated recombination in the skin melanocyte lineage Genesis. 36: 73-80. PMID 12820167 DOI: 10.1002/gene.10197  0.335
2000 Jouneau A, Yu YQ, Pasdar M, Larue L. Plasticity of cadherin-catenin expression in the melanocyte lineage Pigment Cell Research. 13: 260-272. PMID 10952394 DOI: 10.1034/j.1600-0749.2000.130408.x  0.301
1999 Beauvais-Jouneau A, Pla P, Bernex F, Dufour S, Salamero J, Fässler R, Panthier JJ, Thiery JP, Larue L. A novel model to study the dorsolateral migration of melanoblasts Mechanisms of Development. 89: 3-14. PMID 10559475 DOI: 10.1016/S0925-4773(99)00191-4  0.301
1995 Butz S, Larue L. Expression of catenins during mouse embryonic development and in adult tissues Cell Communication and Adhesion. 3: 337-352. PMID 8821035 DOI: 10.3109/15419069509081018  0.306
1994 Larue L, Ohsugi M, Hirchenhain J, Kemler R. E-cadherin null mutant embryos fail to form a trophectoderm epithelium Proceedings of the National Academy of Sciences of the United States of America. 91: 8263-8267. PMID 8058792 DOI: 10.1073/Pnas.91.17.8263  0.305
1993 Larue L, Dougherty N, Bradl M, Mintz B. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma. Oncogene. 8: 523-31. PMID 8382353  0.567
1992 Larue L, Dougherty N, Porter S, Mintz B. Spontaneous malignant transformation of melanocytes explanted from Wf/Wf mice with a Kit kinase-domain mutation. Proceedings of the National Academy of Sciences of the United States of America. 89: 7816-20. PMID 1380168 DOI: 10.1073/Pnas.89.16.7816  0.599
1992 Larue L, Dougherty N, Mintz B. Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes. Proceedings of the National Academy of Sciences of the United States of America. 89: 9534-8. PMID 1329100 DOI: 10.1073/Pnas.89.20.9534  0.608
1991 Porter S, Larue L, Mintz B. Mosaicism of tyrosinase-locus transcription and chromatin structure in dark vs. light melanocyte clones of homozygous chinchilla-mottled mice. Developmental Genetics. 12: 393-402. PMID 1822431 DOI: 10.1002/Dvg.1020120604  0.55
1991 Bradl M, Larue L, Mintz B. Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 88: 6447-51. PMID 1650469 DOI: 10.1073/Pnas.88.15.6447  0.567
1990 Larue L, Mintz B. Pigmented cell lines of mouse albino melanocytes containing a tyrosinase cDNA with an inducible promoter. Somatic Cell and Molecular Genetics. 16: 361-8. PMID 2120778 DOI: 10.1007/Bf01232464  0.575
Show low-probability matches.